Granules India Limited has informed the Exchange regarding a press release dated January 24, 2023, titled "Granules Pharmaceuticals Inc., Receives ANDA Approval for Amphetamine Mixed Salts ER Capsules".
Granules India Limited Press Release Jan 24 2023
Filed with NSE ·
Watch Granules India's latest callGranules India (NSE:GRANULES) Q2 2027 Earnings Call · Replay · Nov 2Read the transcript of Granules India (NSE:GRANULES) Q2 2027 Earnings Call6ix hasn’t read this filing yet.
In the deck
Earlier from Granules India
- Press Release Jan 03 2023
- Press Release Oct 04 2022
- Press Release Aug 30 2022
- Press Release Aug 26 2022
- Press Release May 18 2022
Later from Granules India
- Granules India Limited Press Release Feb 27 2023
- Press Release Mar 21 2023
- Granules India Limited Press Release Mar 29 2023
- Press Release May 16 2023
- Granules India Limited Press Release May 19 2023
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India